Abstract: There are well validated rodent paradigms of schizophrenia which are based on environmental manipulation (e.g. altered rearing conditions) or drug challenges. These manipulations induce behavioural changes in rodents that are thought to involve neuronal circuitry similar to the ones that are affected by the pathophysiology of the disorder. This study has investigated whether three such rodent paradigms (isolation rearing, neonatal PCP treatment or sub-chronic PCP treatment) are associated with changes in muscarinic receptors (CHRMs) or ionotropic glutamate receptors, some of which have been reported to be altered in the CNS of subjects with schizophrenia. 
INTRODUCTION
Schizophrenia appears to manifest in individuals with a genetic predisposition after exposure to environmental factors which trigger the onset of the disorder [1] . This has resulted in the hypothesis that the disorder is an outcome of complex gene x environment interactions. Importantly, it has been noted that both pre-or peri-natal insults are associated with an increased risk of schizophrenia [2] . However, it is not clear how insults at such an early stage in human neurodevelopment can result in a disorder with a peak onset in late adolescence or early adulthood in males and with a 5 year delay in females [3] . The relatively late onset of the disorder has lead to speculation that either early life insults cause changes in neurodevelopment that do not result in functional abnormalities until late in CNS maturation or that schizophrenia results from abnormalities in late stage CNS *Address Correspondence to this author at the Rebecca L. Cooper Research Laboratories, The Mental Health Research Institute, Locked Bag 11, Parkville, Victoria, Australia; Tel: 613-9389-2940; Fax: 613-9387-5061; E-mail: anddali@unimelb.edu.au maturation processes [4] . Whichever hypotheses may be correct, it is now widely accepted that changes in CNS gene expression is an endpoint of the complex gene x environmental interactions that underpin the onset of the symptoms of schizophrenia [1, 5] . At the level of gene expression, there are now considerable bodies of data showing changes in levels of ionotropic glutamate receptors [6] [7] [8] [9] [10] [11] [12] [13] and muscarinic receptors (CHRMs) [7, [14] [15] [16] [17] [18] [19] [20] [21] [22] in the CNS of subjects with the schizophrenia. The possibility that these changes occur because of gene x environment interactions is supported by the demonstration that changing environment can affect levels of ionotropic receptors and CHRMs in the CNS of genetically modified, but not wild type, mice [23, 24] . Given the well documented changes in ionotropic receptors and CHRMs in the CNS from subjects with schizophrenia, knowing how gene x environment interactions can affect the expression of these receptors would be a significant advance in understanding the pathophysiology of the disorder. In this respect, it is significant that N-methyl-D-aspartic acid (NMDA) receptor antagonists such as phencyclidine (PCP) and ketamine induce schizophrenia-like symptoms in humans and worsen symptoms in subjects with schizophrenia [25] . These data, along with that from other lines of research such as postmortem studies [26] , underpin the hypotheses that glutamatergic pathways are involve in the pathophysiology of the disorder [27] . Subsequently, the need to better understand the role of the glutamatergic pathways in the mammalian CNS and how they may be involved in the genesis of schizophrenia lead to the study of the effects of PCP treatment in rodents [28] . Such studies have shown that the acute administration of PCP produces transient behavioural effects thought to be analogous to positive, negative and cognitive symptom domains of schizophrenia (reviewed in [29] ). More recently, longer term PCP treatments (e.g. sub-chronic PCP treatment of adult rats [30] or repeated PCP treatment of neonatal rats (a single administration on post-natal days 7, 9 and 11) [31] has been shown to be advantageous because such treatments produce long term behavioural changes in the absence of the overt neurodegeneration observed after high dose acute PCP treatment [32] . These differences are important because neurodegeneration does not seem to occur in the CNS of subjects with schizophrenia [33] . Moreover, repeated PCP treatment regimes cause long term robust deficits in cognitive function [34, 35] , a heightened response to psychostimulants [36] and deficits in social behaviours [37] [38] [39] along with neuroanatomical changes such as hippocampal and cortical parvalbumin deficits [40, 41] , regional specific changes in N-acetylaspartate [42] , reductions in spine density in pre-frontal cortex [29] and regionally specific changes in BDNF expression [43] , all of which have been reported in the CNS of subjects with schizophrenia. Thus, neonatal and sub-chronic PCP treatment would appear to offer the opportunity to study the impact of a controlled environmental factor on brain development in a rodent model that appears to have relevance to schizophrenia.
Isolation rearing is a rodent paradigm that also alters behaviours such as locomotor activity, pre-pulse inhibition (PPI), responsiveness to psycho-stimulants and cognitive functioning [44, 45] . In addition, rats subjected to isolation rearing have alterations in dopamine and serotonin neurochemistry, volume loss in the prefrontal cortex, reduced N-acetylaspartate in the temporal cortex, reduced hippocampal parvalbumin, reduced prefrontal GAT-1, increased prefrontal NR2A subunit expression, and reduced cortical and hippocampal spine density [43, [45] [46] [47] [48] , all of which have been reported as present in the CNS from subjects with schizophrenia. Importantly, a comparison of results from PCP treatment and isolation rearing suggest that different behavioural phenotypes result from each manipulation (e.g. the reproducible PPI deficit seen in isolation reared rats [45] is not a robust observation following sub-chronic or neonatal PCP administration [49, 50] ). Hence, we postulated that the study of changes in CNS molecular cytoarchitecture across rodent models could reveal different outcomes from gene x environment interactions on the molecular cytoarchitecture that could have relevance to changes that occur in the CNS of subjects with schizophrenia. As the initial step in testing this hypothesis we measured levels of ionotropic glutamate receptors and CHRMs in the CNS of adult rats following either isolation rearing, neonatal or sub-chronic exposure to PCP because levels of these receptors appear to be altered in the CNS from subjects with schizophrenia. 
MATERIALS AND METHODS

Materials
Isolation Reared Rats
Male Lister Hooded rats (Charles River, UK) arrived at the facility on post-natal day (PND) 8-9 with foster mothers [11 pups per female, fostered at birth (PND 0)]. The rat pups used in the isolation rearing paradigm were cross-fostered at PND0 at the breeding facility. Cross-fostering at this age is not known to have any effect on either maternal interaction or overall development. On PND 28, the rats were rehoused singly (isolates) or in groups of five (grouped). In the case of group housing, animals were maintained in large "P2000" cages from Techniplast UK and there is no evidence that these conditions, which exceed stringent minimum requirements outlined by UK home office legislation, causes any stress to the animals. Animals raised under both conditions were housed in the same holding room for a period of 8 weeks before PPI testing. For a full description of isolation rearing and PPI procedure (see [51] ; notably there was significantly impaired PPI in the animals that had undergone isolated rearing (Group housed = 61.8 +/-3.1 %PPI vs. Isolation reared = 5.2 +/-9.2 % PPI; p<0.01, n = 10-12,). Brains were collected for neurochemical analyses close to PND 133.
Neonatal PCP-Treated Rats
Pregnant time-mated Lister Hooded dams were obtained 7 days before parturition (Charles River, UK). In order to allow the dosing on PND7, the rat pups used in the neonatal PCP paradigm were not cross-fostered and disturbances to the litters were minimised prior to the PCP dosing starting on PND 7. Male pups were injected with PCP (10 mg/kg s.c.) on PNDs 7, 9 and 11 which is a well established dosing regimen [31] . Pups were weaned on PND 21 and grown to adulthood (PND 56 onwards). As described previously [52] , the motor activity response to a novel environment was shown to be increased in the PCP treated rats when measured around PND 60 (Box crossings; Vehicle = 76.1 +/-3.2, PCP = 97.3 +/-5.0, n = 45, p<0.01) in animals from which brains were collected for neurochemical analyses on PND 75 for this study.
Sub-Chronic PCP-treated rats
Male Lister Hooded rats (Charles River, UK), approximately 200-220 g at the time of dosing, were administered PCP (1 mg/kg i.p.) or vehicle (saline solution), twice daily (am and pm) for 7 days [30, 53] followed by 7-days washout. Two weeks later brains were collected for neurochemical analyses. Sub-chronic PCP-treated rats were not assessed for behavioural changes, as previous studies in our laboratory have demonstrated a heightened motor activity response to a challenge dose of PCP in every batch of animals tested (>10) [53] .
Tissue Preparation
In all cases, rats were killed by decapitation after stunning and without anaesthesia. Brains were rapidly frozen and stored at -70 o C until required. Subsequently, 25 sequential frozen sections (20µm thick; 3 total binding, 2 non-specific binding for each radioligand) were cut, beginning approximately 4.0 mm posterior to Bregma.
Radioligand Binding with in Situ Autoradiography
Radioligand binding for this study was carried out using single-point saturation analyses; because the radioligand was present at concentrations at least three times that of the Kd for each radioligand, this approach gives a good estimate of total receptor density [54] . . These values were then converted to fmol/mg ETE using the specific activities of the individual radioligands and specific binding calculated by subtracting NSB from TB.
Cresyl Violet Staining
To determine the distribution of radioligand binding, discrete areas of binding on each autoradiograph were compared to the section from which the autoradiograph was generated after the section had been stained with cresyl violet. Cresyl violet staining was performed as described previously [57] after the autoradiographic image had been generated. Thus, sections were fixed in 10% formalin in phosphate buffered saline for 1 hour at RT. Sections were immersed in 0.1% cresyl violet in 1% acetic acid for 15 minutes at 37ºC and then rinsed in dH 2 O. Slides were immersed for 1 minute twice in ethanol and then twice in xylene substitute for 1 minute at RT. Sections were mounted in DPX and imaged using a light microscope with a digital camera attached.
Analysis
In this study, measurements were taken based on discrete areas of radioligand binding and the cytoarchitectural regions included within these regions of binding determined. This approach minimised the number of measurements made and hence lessoned the likelihood of Type 1 errors [58] . All experimental data were interrogated with a Grubb's test to identify any statistically significant outliers, unless stated otherwise, no outlying data was found. The distribution of each data set was assessed using D'Agostino and Pearson omnibus normality and unless stated otherwise data distribution was parametric. Two-way ANOVAs, with either rearing condition or drug treatment and CNS regions as variables were used to identify any variance in radioligand binding. Bonferroni post-hoc tests were then used to identify the source of the variance. For transparency, where outlying data were found, statistically analyses without the outlying data are presented as the primary analyses and the analyses with the outlying data are presented within square brackets.
Results
Muscarinic Receptors: [ 3 H]Pirenzepine Binding
Specific [ 3 H]pirenzepine binding was apparent in the cortex, stratum oriens, stratum lacunosum, strata granulosum, molecular and the polymorphic layer of the dentate gyrus (Fig. 1A) . Cortical [ 3 H]pirenzepine binding was in three layers, Layer 1 containing cortical laminae I and II, Layer 2 containing cortical Laminae III and IV with Layer 3 containing cortical Laminae V and VI [59] . There was an outlying data point in Layer 1 and Layer 3 of one rat in the sub-chronic PCP treated rats ( Table 2) . Table 2 ). There was a significant interaction between the variables (F = 5.7, d.f. = 1,6,140, p < 0.001). The rank order of binding of [ 3 H]pirenzepine across regions showed a change in rank order between polymorphic layer of the dentate gyrus and stratum lacunosum between rearing conditions due to [ 3 H]pirenzepine binding being significantly increased (p = 0.002) in the polymorphic layer of the dentate gyrus and a trend to being decreased (not significant: p = 0.09) in the stratum lacunosum from the isolated reared rats (Table 2; Fig. 1B) . Notably, these changes in 
Muscarinic Receptors: [ 3 H]4DAMP binding
Specific [ 3 H]4DAMP binding could be measured in the cortex, stratum radiatum, dentate gyrus, stratum lacunosum and the stratum oriens (Fig. 1C) . Radioligand binding in the cortex was in two layers with the outer layer of binding encompassing cortical laminae I and II with the inner layer across the remaining laminae of the cortex. Notably, the binding of [ 3 H]4DAMP in the stratum oriens and stratum radiatum could be divided into three discrete layers ( Table  2) . There was an outlying data point for the data from cortical Layer 2 from one rat in the isolated reared animals and in the strata granulosum + molecular from one of the group reared rats. To do 3 H]4DAMP binding indicating the global variation was due to the summed effects of widespread non-significant decreases in radioligand binding in the isolated reared rats (Fig. 1D) . There was no change in the rank order of (Fig. 1E) . The was no change in the rank order of binding. (Fig. 1F) . There was no change in the rank order of binding.
Ionotropic Glutamate Receptors: [ 3 H]Kainate Binding
Specific [ 3 H]kainate binding was measured in the cortex, the CA3 region of the hippocampus and as homogenous low levels of specific [ 3 H]kainate binding across the rest of the hippocampus (Fig. 2A) . There were two layers of cortical binding with Layer 1 encompassing cortical laminae I -III and Layer 2 encompassing cortical laminae IV and VI. For both the neonatal PCP and sub-chronic treatment groups the distribution of [ 3 H]kainate binding was not binomial in the CA 3 region of the vehicle group. However, as the majority of data was normally distributed the more conservative parametric statistic was used for all analyses. Fig. 2C) . Thus, the significant difference in global Table 2 ). There was no interaction between the variables (F = 0.66, d.f. = 3,1,86, p = 0.58). The rank order of regional binding was not changed..
Ionotropic Glutamate Receptors: [ 3 H]MK 801 Binding
Specific [ 3 H]MK 801 binding had the highest number of discrete binding regions (Fig. 2B) . Binding in the cortex was in two layers with Layer 1 encompassing cortical laminae I to III and Layer 2 encompassing cortical laminae IV to VI. In the hippocampus specific binding was measurable in the alveus, CA 1, CA2, CA3 (Strata oriens, pyramidale and radiatum in all CA regions), dentate gyrus (Stratum moleculare and polymorphic layer + Stratum granulosum) and the Stratum lacunosum which was uniformly labelled through the CA. In the neonatal PCP treated animals, an outlier was detected [ 3 H]MK 801 binding for one rat in the alveus of the PCP treated group ( Table 2 ) and an outlier was detected in the Stratum moleculare of the dentate gyrus of one rat receiving sub-chronic PCP treatment.
The distribution of data was shown not to be binomial in the CA1 Stratum oriens, CA2 Stratum pyramidale, CA1 Stratum radiatum and Dentate Gyrus Stratum molecular of the group reared rats in the isolated rearing paradigm. In the neonatal PCP treated rats data was not binomially distributed in Layer 1 of the cortex of the PCP treated group. The data from the entire sub-chronic PCP treated paradigm were normally distributed. Thus, because the majority of data was binomially distributed, the more conservative parametric analyses were completed for all comparisons. Fig. 2D ).
Discussion
This study has shown that there are widespread decreases in [ 3 H]4DAMP binding in the CNS of rats after isolation rearing and sub-chronic PCP treatment. Based on our current understanding of the binding of radioligands used in our study, our data would be consistent with small widespread decreases in KAR after isolation rearing ranging from 3% in Layer 1 of the cortex to 15% in areas of the hippocampus. The data also are consistent with widespread decreases of between 5% (dentate gyrus stratum molecular) and 11% (dentate gyrus stratum granulosum + polymorphic layer) in NMDAR after sub-chronic PCP treatment. Decreases in CHRM3 were less than 7% in the cortex after isolation rearing to between 3.5% in the Stratum oriens layer 1 and 9.8% in the polymorphic layer of the dentate gyrus after sub-chronic PCP treatment. Finally, CHRM3 was increased between 1% in layer 1 of the stratum oriens and 9% in layer 3 of the stratum radiatum after neonatal PCP treatment. These latter two sets of data suggest that the adult and neonatal PCP treatment paradigms may have subtle effects on the expression of CHRM3 in different CNS regions.
In any study of receptor density, it is important to consider whether the magnitude of change is larger than the receptor reserve, which is the number of receptors present in a tissue in excess of that needed for a full physiological response [62] . This is because any change in receptor density which is smaller than the receptor reserve is unlikely to elicit change in receptor signalling of a magnitude that will have any physiologically significant consequence [63] . In this respect, current data suggest that the NMDAR has a large receptor reserve whereas the other ionotropic glutamate receptors have close to no receptor reserve [64] . This suggests that the decreases in NMDARs we report after subchronic PCP treatment are unlikely to be sufficient to cause a change in receptor signalling. By contrast, the absence of any KAR receptor reserve means that the small change in receptor density we report after isolated rearing would result in altered receptor signalling and therefore could be contributing to the behavioural changes observed in these animals. There is a more comprehensive literature on receptor reserve for CHRM function. Hence, in SH-SY5Y cells it has been reported that the overall receptor reserve for signalling by the CHRM agonist carbachol is 50% [65] . Studies using cloned receptors in CHO cells have subsequently suggested that the CHRM3 has a large receptor reserve [66] . In mouse hippocampus, CHRM1 has been reported to have a receptor reserve of 85% [67] whereas the CHRM2 appears to have little to no receptor reserve [68] . There appears to be little or no receptor reserve for CHRMmediated acetylcholine release [68] . Finally, in the cortex, it has been reported that there is a very low receptor reserve with regards to CHRM1 signalling through phosphoinositide pathways whereas there was a high receptor reserve for CHRM2 signalling through cyclic AMP [69] . Hence, at least with CHRMs, it would appear that receptor reserve can vary significantly depending on the signalling pathway being activated.
The KAR, like other ionotropic glutamate receptors, is made up of sub-units [70] from two families of sub-units (GluR 5, 6 and 7 and KA 1 and 2) which have been differentiated on the basis of gene sequence homologies [71] . Notable for this study is that high affinity [ 3 H]kainate binding is to the KA 1 or 2 sub-units [70] . We are not aware of any previous studies examining levels of KAR in the CNS of rats following isolation rearing and therefore our findings of widespread decreases in KAR are novel. It has been reported that 24 hours after a single injection of PCP there is a dose-dependent (0.86, 4.3 or 8.8 mg / kg) increase in KAR in the Cornu Ammonis 3 and dentate gyrus [72] suggesting drugs which target the NMDAR can indirectly affect the density of KAR. Our data did not show any statistically significant changes in the density of KAR in the CNS of adult rats following neonatal or sub-chronic PCP which could suggest any effects of the PCP treatment on KAR is short lived.
Our finding of global decreases in NMDAR after subchronic PCP treatment is in partial agreement with another study that reported a decrease in that receptor after 7 days administration of MK 801 (0.5 mg / kg) to adult rats [73] . In another study it was reported that NMDAR were decreased in 36 day old rats injected with PCP ( 5 mg / kg) from PND 5 to 15 [74] ; this study also reported decreases in levels of NR2B, but not NR1, NR2A or NR2C, sub-unit mRNA. By contrast, PCP (single injection: 0.86, 4.3, 8.8 mg / kg) has been reported to cause a dose-dependent increase in hippocampal [ 3 H]glutamate binding to the NMDAR 24 hr after drug injection [72] . In other studies, using seven day old rats treated with MK 801 (1 mg / kg), there was an increase in mRNA for the NR1, NR2A, NR2B and NR2D NMDAR sub-units in the cortex, hippocampus and striatum 2 to 4 hours after the administration of MK801 [52, 75] . Thus it would seem that the effects of NMDAR antagonists on NMDAR levels may depend on the age of the rats and dosing regimen. This notion is supported by a study that compared the outcome of a single dose of PCP (10 mg / kg) on PN7 (rats sacrificed after 0, 4, 8 or 24 hr) to that of multiple injections of the same does of PCP on PND 7, 9 and 11 (rats sacrificed after 24 hr) [76] . The single injection of PCP increased the levels of cortical NR1 and NR2B, but not NR2A, sub-units of the NMDAR whereas repeated PCP injections increased cortical NR1 and NR2A, but not NR2B, sub-units of the NMDAR. Our study has shown that repeated injection of PCP during the neonatal period does not change levels of NMDAR in the adult CNS suggesting any effects of injecting PCP on NMDAR density is not long lasting.
This study has shown there are small widespread changes in levels of CHRM3 following isolation rearing (< -7.5 %), neonatal PCP administration (1 to 9%) and sub-chronic PCP treatment (4 to 10%). However, none of these changes in CHRM3 exceed the CHRM3 receptor reserve and thus are unlikely to be of a sufficient magnitude to have significant physiological outcomes. This hypothesis needs to be treated with some caution as it has been shown that apparent receptor reserves differ for different CHRM / signalling pathway interactions and thus it may be premature to totally exclude the possibility that such small changes in CHRM3 density are having effects on signalling pathways and hence cellular function. In this study, there was no change in [ 3 H]pirenzepine binding in any paradigm which differs from a previous study that showed complex changes in [ 3 H]pirenzepine following neonatal PCP treatment, culminating in a 10% increase in binding in the cortex of adult rats after drug treatment [77] .
In conclusion, this study shows that animal models developed to study the pathophysiology of schizophrenia cause differential changes in the molecular cytoarchitecture of the CNS. However, neither isolation rearing nor PCP treatment caused changes in the molecular cytoarchitecture of the CNS in rodent that have been reported in the CNS of subjects with schizophrenia. Significantly, ongoing studies of the CNS from subjects with schizophrenia are revealing that extensive changes in gene expression are associated with the disorder [78] and it is therefore likely that changes in the expression of some of these genes will occur in different animal models of the disorder. The challenge will therefore be to identify an animal model that has a change in CNS expression of a specific gene which mirrors what occurs in the CNS from subjects with schizophrenia. For example, our data shows a decrease in KAR after isolation rearing and some studies report decrease in KAR in schizophrenia [6, 9, 79, 80] . Hence, further study of KAR in rats following isolation rearing should allow a greater understanding as to how exposure to such an environmental factor earlier in life can cause changes in the expression of a gene similar to those observed in subjects with schizophrenia. 
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